Kardiolytics Inc.

Calculating rank

USPTO Granted Patents = 6

EPO Patents = 4

Forward Citations = 3

Loading Chart...

8 inventors (with patents filed for the assignee):

Wojciech Sadowski (5 out of 5 patents)

Zbigniew Malota (5 out of 5 patents)

Kris Siemionow (4 out of 7 patents)

4. Marek Kraft (4 out of 8 patents)

5. Dominik Pieczynski (4 out of 6 patents)

6. Paul Lewicki (4 out of 6 patents)

7. Jacek Kania (4 out of 4 patents)

8. Michal Mikolajczak (1 out of 3 patents)

6 patents: Sort by Forward Citations

1. 12387337 - Autonomous segmentation of contrast filled coronary artery vessels on computed tomography images (2025-08-12),

2. 12067675 - Autonomous reconstruction of vessels on computed tomography images (2024-08-20),

3. 12051511 - Modelling blood vessels and blood flow (2024-07-30),

4. 11626211 - Modelling blood vessels and blood flow (2023-04-11),

5. 11521322 - Method and system for machine learning based segmentation of contrast filled coronary artery vessels on medical images (2022-12-06),

6. 11315293 - Autonomous segmentation of contrast filled coronary artery vessels on computed tomography images (2022-04-26),

Company Overview

Kardiolytics Inc. is a leading biotech company specializing in innovative solutions for cardiovascular diagnostics. Our state-of-the-art technology allows for early detection and monitoring of heart conditions, providing patients and healthcare professionals with valuable insights to improve heart health. With a focus on precision and accuracy, Kardiolytics is dedicated to advancing the field of cardiology through groundbreaking research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#88 in Tulsa, OK

#229 in Oklahoma

#45,030 in US

Tulsa, OK, United States of America

Kardiolytics Inc.

Forward Citations = 3

8 inventors:

Wojciech Sadowski (5 out of 5 patents)

Zbigniew Malota (5 out of 5 patents)

Kris Siemionow (4 out of 7 patents)

4. Marek Kraft (4 out of 8 patents)

5. Dominik Pieczynski (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kardiolytics Inc.. Retrieved from https://idiyas.com/company/kardiolytics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]